The abstract is read at the publisher; the summary is JClub's.
Neuropathological evidence indicates SOD1 misfolding and aggregation co-occur with multiple proteinopathies in the human brain, including TDP-43, tau, alpha-synuclein, and amyloid-β.
- Why it matters: The field needs to clarify whether SOD1 pathology is confined to amyotrophic lateral sclerosis or instead participates in broader, interconnected neurodegenerative processes.
- What they did: This review synthesizes human neuropathological findings on where pathological SOD1 species appear across diseases and how they coexist with other aggregation-prone proteins, considering mechanisms like oxidative stress, impaired proteostasis, phase separation, and cross-seeding.
- The result: The compiled evidence supports shifting SOD1 from a disease-specific marker toward a potential component of proteopathic networks, informing biomarker and therapeutic target development despite incomplete understanding of functional significance.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.